Lake Street Capital Markets Starts Intermolecular (IMI) at Buy

Lake Street Capital Markets initiates coverage on Intermolecular (NASDAQ: IMI) with a Buy rating and a price target of $3.00.

Analyst Jason Schmidt is positive on management's efforts to retool the company to address the increasingly complex manufacturing environment.

For an analyst ratings summary and ratings history on Intermolecular click here. For more ratings news on Intermolecular click here.

Shares of Intermolecular closed at $1.61 yesterday.

You May Also Be Interested In

• William Blair Starts First Advantage (FA) at Outperform, 'Best-in-Class Background Screener'
• Invesco (IVZ) PT Lowered to $17 at BMO Capital
• Novartis (NVS) PT Raised to $108 at CFRA